Second generation intervention research in the pre-psychotic phase of illness in schizophrenia and related psychoses

Phase 4

Completed

• Conditions: Schizophrenia and other psychotic disorders; Mental Health - Schizophrenia; Mental Health - Other mental health disorders

• Registration Number: ACTRN12605000247673
• Lead Sponsor: Janssen-Cilag Pharmaceuticals

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-08-31
• Study Completion: 2006-04-12
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 119

Inclusion Criteria

Participants must meet 'ultra high risk' criteria as outlined in Yung, Phillips and McGorry (2004) Treating Schizophrenia in the Prodromal Phase. London: Taylor nd Francis. Also, have not previously experienced psychotic episode, IQ > 70, adequate English skills, and living in Melbourne metro area.

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified